PART TWO
Diagnostic Cytology
135. Pangalis GA, Boussiotis VA, Kittas C.
Malignant disorders of small lym-
phocytes. Small lymphocytic lym-
phoma, lymphoplasmacytic lymphoma,
and chronic lymphocytic leukemia: their
clinical and laboratory relationship.
Am
J Clin Pathol
1993;99(4):402-408.
136. Brecher M, Banks PM. Hodgkin's
disease variant of Richter's syndrome.
Report of eight cases.
Am J Clin Pathol
1990;93(3):333-339.
137. Berger F, Felman P, Sonet A, et al.
Nonfollicular small B-cell lymphomas:
a heterogeneous group of patients with
distinct clinical features and outcome.
Blood
1994;83(10):2829-2835.
138. Pugh WC, Manning JT, Butler JJ.
Paraimmunoblastic variant of small
lymphocytic lymphoma/leukemia.
Am J
Surg Pathol
1988;12(12):907-917.
139. Lin P, Medeiros LJ. Lymphoplasmacytic
lymphoma/Waldenstrom macroglob-
ulinemia: an evolving concept.
Adv Anat
Pathol
2005;12(5):246-255.
140. Patsouris E, Noel H, Lennert K. Lym-
phoplasmacytic/lymphoplasmacytoid
immunocytoma with a high content of
epithelioid cells. Histologic and immu-
nohistochemical findings.
Am J Surg
Pathol
1990;14(7):660-670.
141. O'Briain DS, Kennedy MJ, Daly PA, et
al. Multiple lymphomatous polyposis
of the gastrointestinal tract. A clin-
icopathologically distinctive form of
non-Hodgkin's lymphoma of B-cell
centrocytic type.
Am J Surg Pathol
1989;13(8):691-699.
142. Lardelli P, Bookman MA, Sundeen J,
et al. Lymphocytic lymphoma of inter-
mediate differentiation. Morphologic
and immunophenotypic spectrum and
clinical correlations.
Am J Surg Pathol
1990;14(8):752-763.
143. Fisher RI, Dahlberg S, Nathwani BN, et
al. A clinical analysis of two indo-
lent lymphoma entities: mantle cell
lymphoma and MZL (including the
mucosa-associated lymphoid tissue and
monocytoid B-cell subcategories): a
Southwest Oncology Group study.
Blood
1995;85(4):1075-1082.
144. Wojcik EM, Katz RL, Fanning TV, et al.
Diagnosis of mantle cell lymphoma on
tissue acquired by fine needle aspira-
tion in conjunction with immuno-
cytochemistry and cytokinetic studies.
Possibilities and limitations.
Acta Cytol
1995;39(5):909-915.
145. Hughes JH, Caraway NP, Katz RL.
Blastic variant of mantle-cell lymphoma:
cytomorphologic, immunocytochemical,
and molecular genetic features of tissue
obtained by fine-needle aspiration biopsy.
Diagn Cytopathol
1998;19(1):59-62.
146. Koo CH, Rappaport H, Sheibani K, et al.
Imprint cytology of non-Hodgkin's lym-
phomas based on a study of 212 immuno-
logically characterized cases: correlation of
touch imprints with tissue sections.
Hum
Pathol
1989;20(12 suppl. 1):1-137.
147. Bennett JM, Catovsky D, Daniel MT,
et al. Proposals for the classification of
chronic (mature) B and T lymphoid
leukaemias. French-American-British
(FAB) Cooperative Group.
J Clin Pathol
1989;42(6):567-584.
148. Bell PB, Rooney N, Bosanquet AG.
CD79a detected by ZL7.4 separates
chronic lymphocytic leukemia from
mantle cell lymphoma in the leukemic
phase.
Cytometry
1999;38(3):102-105.
149. Kwak LW, Wilson M, Weiss LM, et al.
Clinical significance of morphologic
subdivision in diffuse large cell lym-
phoma.
Cancer
1991;68(9):1988-1993.
150. Haralambieva E, Pulford KA, Lamant L,
et al. Anaplastic large-cell lymphomas
of B-cell phenotype are anaplastic
lymphoma kinase (ALK) negative
and belong to the spectrum of diffuse
large B-cell lymphomas.
Br J Haematol
2000;109(3):584-591.
151. Delabie J, Vandenberghe E, Kennes C,
et al. Histiocyte-rich B-cell lymphoma.
A distinct clinicopathologic entity
possibly related to lymphocyte pre-
dominant Hodgkin's disease, para-
granuloma subtype.
Am J Surg Pathol
1992;16(1):37-48.
152. Arber D, Weiss L. CD5:a review.
Appl
Immunohistochem
1995;3:1-22.
153. Doggett RS, Wood GS, Horning S, et al.
The immunologic characterization of
95 nodal and extranodal diffuse large
cell lymphomas in 89 patients.
Am J
Pathol
1984;115(2):245-252.
154. Cleary ML, Trela Mj, Weiss LM, et al.
Most null large cell lymphomas
are B lineage neoplasms.
Lab Invest
1985;53(5):521-525.
155. Weiss LM, Warnke RA, Sklar J, et al. Molec-
ular analysis of the t(14;18) chromosomal
translocation in malignant lymphomas.
N
Engf J Med
1987;317(19): 1185-1189.
156. Jaffe E, Harris N, Diebold J, et al. World
Health Organization classification of
neoplastic diseases of the hematopoi-
etic and lymphoid tissues. A progress
report.
Am J Clin Pathol
1999;111(suppl
1):S8-S12.
157. Chott A, Kaserer K, Augustin I, et al.
Ki-1-positive large cell lymphoma. A
clinicopathologic study of 41 cases
[see comments].
Am J Surg Pathol
1990;14(5):439-448.
158. Benharroch D, Meguerian-Bedoyan
Z, Lamant L, et al. ALK-positive
lymphoma: a single disease with a
broad spectrum of morphology.
Blood
1998;91(6):2076-2084.
159. Ng WK, Ip P, Choy C, et al. Cytologic
and immunocytochemical findings
of anaplastic large cell lymphoma:
analysis of ten fine-needle aspiration
specimens over a 9-year period.
Cancer
2003;99(1):33-43.
160. Arber D, Weiss L. CD43: a review.
Appl
Immunohistochem
1993;1:88-96.
161. Delsol G, Al Saati T, Gatter KC, et al.
Coexpression of epithelial membrane
antigen (EMA), Ki-1, and interleukin-2
receptor by anaplastic large cell lym-
phomas. Diagnostic value in so-called
malignant histiocytosis.
Am J Pathol
1988;130(1):59-70.
162. Penny RJ, Blaustein JC, Longtine JA,
et al. Ki-1-positive large cell lym-
phomas, a heterogenous group of
neoplasms. Morphologic, immunophe-
notypic, genotypic, and clinical features
of 24 cases.
Cancer
1991;68(2):
362-373.
163. Shiota M, Nakamura S, Ichinohasama
R, et al. Anaplastic large cell lymphomas
expressing the novel chimeric protein
p80NPM/ALK: a distinct clinicopatho-
logic entity.
Blood
1995;86(5):1954-1960.
164. Spits H, Blom B, Jaleco AC, et al. Early
stages in the development of human T,
natural killer and thymic dendritic cells.
Immunol Rev
1998;165:75-86.
165. Lopez-Guillermo A, Cid J, Salar A, et
al. Peripheral T-cell lymphomas: initial
features, natural history, and prognostic
factors in a series of 174 patients
diagnosed according to the R.E.A.L.
classification.
Ann Oncol
1998;9(8):
849-855.
166. Cabanillas F, Pathak S, Grant G, et al.
Refractoriness to chemotherapy and
poor survival related to abnormalities
of chromosomes 17 and 7 in lym-
phoma.
Am J Med
1989;87(2):167-172.
167. Park IA, Kim CW. FNAC of malignant
lymphoma in an area with a high inci-
dence of T-cell lymphoma. Correlation
of accuracy of cytologic diagnosis with
histologic subtype and immunopheno-
type.
Acta Cytol
1999;43(6):1059-1069.
168. Harris NL, Jaffe ES, Stein H, et al. A
revised European-American clas-
sification of lymphoid neoplasms:
a proposal from the International
Lymphoma Study Group.
Blood
1994;84(5):1361-1392.
169. McClure RF, Remstein ED, Macon WR,
et al. Adult B-cell lymphomas with
Burkitt-like morphology are phenotypi-
cally and genotypically heterogeneous
with aggressive clinical behavior.
Am J
Surg Pathol
2005;29(12):1652-1660.
170. Cogliatti SB, Novak U, Henz S, et al.
Diagnosis of Burkitt lymphoma in due
time: a practical approach.
Br J Haema-
tol
2006;134(3):294-301.
171. Kanungo A, Medeiros LJ, Abruzzo LV, et
al. Lymphoid neoplasms associated with
concurrent t(14;18) and 8q24/c-MYC
translocation generally have a poor prog-
nosis.
Mod Pathol
2006;19(1):25-33.
172. Troxell ML, Bangs CD, Cherry AM, et al.
Cytologic diagnosis of Burkitt lym-
phoma.
Cancer
2005;105(5):310-318.
173. Divine M, Casassus P, Koscielny S, et al.
Burkitt lymphoma in adults: a prospec-
tive study of 72 patients treated with an
adapted pediatric LMB protocol.
Ann
Oncol
2005;16(12):1928-1935.
174. Dave SS, Fu K, Wright GW, et al. Molec-
ular diagnosis of Burkitt's lymphoma.
N Engl J Med
2006;354(23):2431-2442.
175. Hummel M, Bentink S, Berger H, et al.
A biologic definition of Burkitt's
lymphoma from transcriptional and
genomic profiling.
N Engl J Med
2006;354(23):2419-2430.
176. Nathwani BN, Diamond LW, Winberg
CD, et al. Lymphoblastic lymphoma: a
clinicopathologic study of 95 patients.
Cancer
1981;48(11):2347-2357.
177. Coleman CN, Picozzi VJ Jr, Cox RS, et al.
Treatment of lymphoblastic lymphoma in
adults.
J Clin Oncol
1986;4(11):1628-1637.
178. Sheibani K, Winberg CD, Burke JS, et al.
Lymphoblastic lymphoma expressing
natural killer cell-associated antigens:
a clinicopathologic study of six cases.
Leuk Res
1987;11(4):371-377.
710
previous page 702 ComprehensiveCytopathology 1104p 2008 read online next page 704 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off